… The overall risk of delirium after surgery was 14.5% (n=5957). Dexmedetomidine (odds ratio 0.46, 95% credible interval 0.36 to 0.57), corticos…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 73 of 2459…chomatis (CT)), trichomoniasis (Trichomonas vaginalis (TV)) and bacterial vaginosis (BV). The performance of this approach depends on its clinical …
…rable variability, and their efficacy remains ambiguous.Methods PubMed, Embase, Web of Science and CENTRAL were searched for randomise…
… The safety profile was similar to that previously observed for fasinumab.Trial registration number NCT03161093.…
…5, Claude 3.7 Sonnet, Grok-2, Deepseek Cognition V2, Qwen2 72B, Gemini 2.0 Pro, Llama 3 405B and Mixtral 8×22B) on their ability to interpret …
…Amyotrophic lateral sclerosis (ALS) is a motor neuron disease (MND) characterised by progress…
…ulation characteristics and risk factors suggest that NASAH and aSAH arise from fundamentally different pathophysiological mechanism…
…valuating the efficacy of disease-modifying therapies (DMTs) in multiple sclerosis (MS) using French registry data.Methods This multicentre, retro…
…alcohol use disorder (AUD) receive medications for AUD, such as acamprosate. Medications for AUD may decrease progression of ALD. Challenge…
…) at the First Affiliated Hospital of Xiamen University and the Second Hospital of Hebei Medical University between January 2017 and December 2020. In addition, 6054 PIH r…
…cribed (%) N = 76 Improvement (%) p-value Significant? (p<0.05) Aspirin 221 (100) 76 (100) 0 - - Beta-blocker 156 (70.6) 69 (90.8) +20.…